Angeion takes new direction with diagnostics acquisition
This article was originally published in Clinica
Executive Summary
ICD company Angeion is to buy diagnostics company Medical Graphics, which develops systems for the diagnosis and management of heart and lung disease, for $2.15 a share, or a total of $16.3 million, a premium on Medical's current share price.